Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Accounts Payables (2022 - 2025)

CervoMed (CRVO) has disclosed Accounts Payables for 9 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Accounts Payables fell 3.79% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, down 3.79% year-over-year, with the annual reading at $1.5 million for FY2025, 3.79% down from the prior year.
  • Accounts Payables hit $1.5 million in Q4 2025 for CervoMed, up from $1.3 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $1.9 million in Q1 2025 to a low of $97302.0 in Q4 2022.
  • Historically, Accounts Payables has averaged $1.0 million across 4 years, with a median of $889229.5 in 2022.
  • Biggest YoY gain for Accounts Payables was 580.84% in 2023; the steepest drop was 33.89% in 2023.
  • Year by year, Accounts Payables stood at $97302.0 in 2022, then soared by 580.84% to $662471.0 in 2023, then skyrocketed by 128.15% to $1.5 million in 2024, then dropped by 3.79% to $1.5 million in 2025.
  • Business Quant data shows Accounts Payables for CRVO at $1.5 million in Q4 2025, $1.3 million in Q3 2025, and $1.8 million in Q2 2025.